In particular, no correlations emerged between DSS, RFS, and MFS with clinicopathological variables (histological grade, tumor size, age, mitosis, necrosis, Demicco score risk), unlike what was reported by Gold and Barthelmess [14,25], and molecular features (TERT promoter mutations [14,21,25,29] and NAB2-STAT6 fusion transcripts variants). This evidence concerns the gene NAB2 and neoplasm.